Cite
APA Citation
Johne, A., Scheible, H., Becker, A., Van Lier, J., & Meyring, M. (n.d.). 369 Open-label, single center, phase I trial to investigate the mass balance and absolute bioavailability of the oral c-Met inhibitor tepotinib. European journal of cancer, 51, S77–. http://access.bl.uk/ark:/81055/vdc_100030628020.0x00004e